These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 32190657

  • 1. Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq.
    Amin SS, Jalal SD, Ali KM, Mohammed AI, Rasool LK, Osman TJ.
    Biomed Res Int; 2020; 2020():2807120. PubMed ID: 32190657
    [Abstract] [Full Text] [Related]

  • 2. Complications of β-thalassemia intermedia in Iran during 1996-2010 (single-center study).
    Rafsanjani KA, Mafi N, Tafreshi RI.
    Pediatr Hematol Oncol; 2011 Sep; 28(6):497-508. PubMed ID: 21728720
    [Abstract] [Full Text] [Related]

  • 3. Molecular Basis of β-Thalassemia Intermedia in Erbil Province of Iraqi Kurdistan.
    Shamoon RP, Al-Allawi NA, Cappellini MD, Di Pierro E, Brancaleoni V, Granata F.
    Hemoglobin; 2015 Sep; 39(3):178-83. PubMed ID: 25902180
    [Abstract] [Full Text] [Related]

  • 4. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study.
    Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned MS, El-Chafic AH, Fasulo MR, Cappellini MD.
    Blood; 2010 Mar 11; 115(10):1886-92. PubMed ID: 20032507
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular Characterization and Disease-Related Morbidities of β-Thalassemia Patients from the Northeastern Part of Iraq.
    Amin S, Jalal S, Ali K, Rasool L, Osman T, Ali O, M-Saeed A.
    Int J Gen Med; 2020 Mar 11; 13():1453-1467. PubMed ID: 33335418
    [Abstract] [Full Text] [Related]

  • 7. β -thalassemia intermedia in Northern Iraq: a single center experience.
    Al-Allawi NA, Jalal SD, Mohammad AM, Omer SQ, Markous RS.
    Biomed Res Int; 2014 Mar 11; 2014():262853. PubMed ID: 24719849
    [Abstract] [Full Text] [Related]

  • 8. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V, Rigoli L, Lacquaniti A, Salpietro V, Piraino B, Amorini M, Salpietro C, Arrigo T.
    Eur J Haematol; 2015 May 11; 94(5):404-12. PubMed ID: 25200112
    [Abstract] [Full Text] [Related]

  • 9. Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia.
    Musallam KM, Cappellini MD, Wood JC, Motta I, Graziadei G, Tamim H, Taher AT.
    Haematologica; 2011 Nov 11; 96(11):1605-12. PubMed ID: 21791471
    [Abstract] [Full Text] [Related]

  • 10. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.
    Belhoul KM, Bakir ML, Saned MS, Kadhim AM, Musallam KM, Taher AT.
    Ann Hematol; 2012 Jul 11; 91(7):1107-14. PubMed ID: 22281991
    [Abstract] [Full Text] [Related]

  • 11. Clinical and Molecular Characteristics of Non-Transfusion-Dependent Thalassemia in Kuwait.
    Adekile AD, Azab AF, Al-Sharida SI, Al-Nafisi BA, Akbulut N, Marouf RA, Mustafa NY.
    Hemoglobin; 2015 Jul 11; 39(5):320-6. PubMed ID: 26076396
    [Abstract] [Full Text] [Related]

  • 12. β-Thalassemia mutations in the Kurdish population of northeastern Iraq.
    Jalal SD, Al-Allawi NA, Bayat N, Imanian H, Najmabadi H, Faraj A.
    Hemoglobin; 2010 Jul 11; 34(5):469-76. PubMed ID: 20854121
    [Abstract] [Full Text] [Related]

  • 13. Transfusion requirements and complication rate in β-thalassemia intermedia due to heterozygous β-globin gene mutation and triplicated α-globin genes.
    Bonello-Palot N, Benoit A, Agouti I, Hamouda I, Brousse V, NaThalY NetworkRegistre NaThalY, AP-HM, Marseille, France., Badens C.
    Eur J Haematol; 2023 Nov 11; 111(5):742-747. PubMed ID: 37519097
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of endocrine complications in beta-thalassemia intermedia (β-TI): a cross-sectional multicenter study.
    Karimi M, Zarei T, Haghpanah S, Azarkeivan A, Kattamis C, Ladis V, Kattamis A, Kilinc Y, Daar S, Alyaarubi S, Khater D, Wali Y, Elshinawy M, Almadhani A, Yassin M, Soliman AT, Canatan D, Obiedat M, Al-Rimawi H, Mariannis D, Christodoulides C, Christou S, Tzoulis P, Campisi S, Di Maio S, De Sanctis V.
    Endocrine; 2020 Jul 11; 69(1):220-227. PubMed ID: 31853840
    [Abstract] [Full Text] [Related]

  • 15. Clinical Laboratory Manifestation and Molecular Diagnosis of β-Thalassemia Patients in Iraq.
    AlMosawi RHN, Al-Rashedi NAM, Ayoub NI.
    J Pediatr Hematol Oncol; 2020 Jan 11; 42(1):27-31. PubMed ID: 31714438
    [Abstract] [Full Text] [Related]

  • 16. Updated Molecular Spectrum of β-Thalassemia Mutations in Duhok Province, Northern Iraq: Ethnic Variation and the Impact of Immigration.
    Atroshi SD, Al-Allawi NAS, Eissa AA.
    Hemoglobin; 2021 Jul 11; 45(4):239-244. PubMed ID: 34794358
    [Abstract] [Full Text] [Related]

  • 17. Association between Different Polymorphic Markers and β-Thalassemia Intermedia in Central Iran.
    Sajadpour Z, Amini-Farsani Z, Motovali-Bashi M, Yadollahi M, Khosravi-Farsani N.
    Hemoglobin; 2020 Jan 11; 44(1):27-30. PubMed ID: 31899996
    [Abstract] [Full Text] [Related]

  • 18. Genetic Modifiers in β-Thalassemia Intermedia: A Study on 102 Iraqi Arab Patients.
    Al-Allawi NA, Puehringer H, Raheem RA, Oberkanins C.
    Genet Test Mol Biomarkers; 2015 May 11; 19(5):242-7. PubMed ID: 25751242
    [Abstract] [Full Text] [Related]

  • 19. Genotype/Phenotype Correlation of β-Thalassemia in Syrian Patients: A Cross-Sectional Study.
    Shoujaa A, Moasses F, Mukhalalaty Y, Murad H, Al-Quobaili F.
    Hemoglobin; 2020 Jan 11; 44(1):42-46. PubMed ID: 31903828
    [Abstract] [Full Text] [Related]

  • 20. Risk factors for pulmonary hypertension in patients with β thalassemia intermedia.
    Karimi M, Musallam KM, Cappellini MD, Daar S, El-Beshlawy A, Belhoul K, Saned MS, Temraz S, Koussa S, Taher AT.
    Eur J Intern Med; 2011 Dec 11; 22(6):607-10. PubMed ID: 22075289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.